Charles River Laboratories (CRL)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$288.50-1.65%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · CRL
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 6.0% |
| Our one-year growth estimate | diamond | -0.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Usually moved in the opposite direction.
Price observations: 365 days
Most sensitive to the broad stock market and real (inflation-adjusted) rates.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 6.2 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 32 industry peers · Company calendar date is not available
CRL — officer change
Dated 2026-05-11
The filing is about the approval of a new long-term incentive plan, not a management change.
Why it matters: More bookings in the DSA segment would show positive demand trends. This supports revenue growth.
Supportive ifDSA segment bookings increase year over year in Q2 2026.
Worry ifDSA segment bookings decline year over year in Q2 2026.
Why it matters: Changes in revenue from selling parts of the business show if management works well.
Worry ifQ3 revenue fell due to divestitures over 4.5%.
Less concerning ifQ3 revenue fell due to divestitures below 4.5%.
Why it matters: Stock buybacks show that management wants to give value to shareholders.
Supportive ifThey announced stock buybacks of at least $100 million in Q3.
Worry ifNo stock repurchase announcements in Q3.
Why it matters: Negative growth means ongoing problems in key areas. This could affect future plans.
Worry ifQ3 organic revenue growth reported below 0% year over year.
Less concerning ifQ3 organic revenue growth reported above 0% year over year.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$167 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $397 loss on $10,000 · 4.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,388 loss on $10,000 · 33.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Finishing this sale shows that management is making progress with its plans.
Supportive ifLook for a press release or 8-K filing to confirm the sale is done.
Worry ifNo news about the sale being finished by the end of Q3.
Why it matters: Changes in EPS guidance can show shifts in profit expectations. This can affect how investors feel.
Watch forNon-GAAP EPS guidance raised above $11.20.
Also watch forNon-GAAP EPS guidance lowered below $10.70.
Why it matters: Ongoing stock buybacks show that management is confident. This can help stock value.
Supportive ifThey announced more stock buybacks over $100 million.
Worry ifNo new announcements on stock repurchases for the next quarter.
Why it matters: If growth exceeds 1%, it shows strong demand recovery in the DSA segment.
Supportive ifQ3 organic revenue growth was above 1%.
Worry ifQ3 organic revenue growth was below 0%.
Why it matters: If the company grows its revenue again, it shows demand is back. This also shows that recent strategies are working.
Supportive ifOrganic revenue growth in Q2 2026 reported as at least flat compared to Q1 2026.
Worry ifOrganic revenue continues to decline year over year in Q2 2026.
Why it matters: Changes in earnings guidance show how much management trusts future results.
Watch forManagement raises non-GAAP EPS guidance for 2026 to above $10.80.
Also watch forManagement lowers non-GAAP EPS guidance for 2026 to below $10.70.
Why it matters: Higher margins show better efficiency and cost control.
Supportive ifNon-GAAP operating margin is better than in Q1 2026.
Worry ifNon-GAAP operating margin drops more in Q2 2026.
Why it matters: Stable revenue in the DSA segment is key for the company's performance.
Watch forQ3 DSA segment revenue shows growth or stability compared to last year.
Also watch forQ3 DSA segment revenue fell compared to last year.
Why it matters: New acquisitions could enhance growth and align with Charles River's core strengths.
Supportive ifA new acquisition that fits with main skills is announced.
Worry ifNo news on acquisitions or delays in planned deals.
Why it matters: Finishing this sale will help the company focus on its main strengths. It will also make operations more efficient.
Supportive ifThe company will announce the sale is complete by the end of May 2026.
Worry ifThere may be a delay or cancellation of the planned sale.